Management of Invasive Candidiasis in the Intensive Care Unit View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2010-05

AUTHORS

E. Geoffrey Playford, Jeff Lipman, Tania C. Sorrell

ABSTRACT

Invasive candidiasis (IC) is an important infection in the intensive care unit (ICU) setting given its association with poor clinical outcomes. The epidemiology of IC is complex and, although incompletely elucidated, is characterized by considerable regional and temporal variability. Overall, there appears to be an increase in the incidence of IC and a change in distribution of the causative Candida spp. Of particular concern is an increase in the proportion of episodes caused by Candida glabrata, which is associated with reduced susceptibility to azole antifungal agents.The management of IC has been aided by the availability of several new antifungal agents. In particular, given their broad spectrum of activity and low toxicity, the use of echinocandins as first-line therapy is increasing, especially in settings where fluconazole-resistant Candida spp. are prevalent. Fluconazole remains a reliable agent where an azole-susceptible pathogen is confirmed or in settings where resistance is uncommon. Lipid formulations of amphotericin B are now generally reserved as second-line or salvage therapy. Voriconazole and posaconazole currently enjoy limited use for IC in the ICU setting.Although the poor outcomes associated with IC are, in part, related to the severity of underlying host factors, it is clear that optimization of treatment-related factors is also important. In particular, the speed of initiation of antifungal therapy and the achievement of pharmacodynamic parameters both influence outcomes. The most difficult challenge is early initiation of an effective antifungal drug, given the slow turnaround time and lack of sensitivity of conventional culture-based diagnostic techniques. New approaches, such as non-culture-based assays and/or clinical risk-predictive models are required to better target prophylactic, pre-emptive and empirical antifungal strategies. More... »

PAGES

823-839

References to SciGraph publications

  • 2006-02-10. Epidemiological trends in nosocomial candidemia in intensive care in BMC INFECTIOUS DISEASES
  • 2005-10-25. The use of prophylactic fluconazole in immunocompetent high-risk surgical patients: a meta-analysis in CRITICAL CARE
  • 1997-05. Multicenter randomized trial of fluconazole versus amphotericin B for treatment of candidemia in non-neutropenic patients in EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
  • 2004-05-19. Combined Assessment of β-d-Glucan and Degree of Candida Colonization before Starting Empiric Therapy for Candidiasis in Surgical Patients in WORLD JOURNAL OF SURGERY
  • 2007-02-27. Multicenter retrospective development and validation of a clinical prediction rule for nosocomial invasive candidiasis in the intensive care setting in EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
  • 2000-12-08. Influence of continuous veno–venous haemodiafiltration and continuous veno–venous haemofiltration on the pharmacokinetics of fluconazole in EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
  • 2009-06-26. Antifungal treatment for invasive Candida infections: a mixed treatment comparison meta-analysis in ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS
  • 2008-11-15. Risk-based fluconazole prophylaxis of Candida bloodstream infection in a medical intensive care unit in EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
  • 2005-09-30. Oral nystatin prophylaxis of Candida spp. colonization in ventilated critically ill patients in INTENSIVE CARE MEDICINE
  • 1996-04. Predominant pathogens found in the European prevalence of infection in intensive care study in EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
  • 2007-10-02. Candidemia and candiduria in critically ill patients admitted to intensive care units in France: incidence, molecular diversity, management and outcome in INTENSIVE CARE MEDICINE
  • 2005-09-30. Oral nystatin as antifungal prophylaxis in critically ill patients: an old SDD tool to be renewed? in INTENSIVE CARE MEDICINE
  • 2003-09-10. Candidemia in critically ill patients: difference of outcome between medical and surgical patients in INTENSIVE CARE MEDICINE
  • 2003-01-25. Duration of Antifungal Treatment and Development of Delayed Complications in Patients with Candidaemia in EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
  • 2008-10-30. Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: Part II. Treatment in INTENSIVE CARE MEDICINE
  • 2009-02-11. Is Candida colonization of central vascular catheters in non-candidemic, non-neutropenic patients an indication for antifungals? in INTENSIVE CARE MEDICINE
  • 2005-09-20. Prophylaxis of Candida infections in adult trauma and surgical intensive care patients: a systematic review and meta-analysis in INTENSIVE CARE MEDICINE
  • 1996-12. Occurrence of yeast bloodstream infections between 1987 and 1995 in five Dutch university hospitals in EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
  • 2010-01. Augmented Renal Clearance in CLINICAL PHARMACOKINETICS
  • 2009-09-15. Assessment of clinical risk predictive rules for invasive candidiasis in a prospective multicentre cohort of ICU patients in INTENSIVE CARE MEDICINE
  • 2009-07-13. Determinants of mortality in non-neutropenic ICU patients with candidaemia in CRITICAL CARE
  • 1996-11. A randomized study comparing fluconazole with amphotericin B/5-flucytosine for the treatment of systemicCandida infections in intensive care patients in INFECTION
  • 1997-01. Candidemia in non-neutropenic critically ill patients: analysis of prognostic factors and assessment of systemic antifungal therapy in INTENSIVE CARE MEDICINE
  • 2009-02-11. On track to limit antifungal overuse! in INTENSIVE CARE MEDICINE
  • 2008-08-29. Fungal colonization and/or infection in non-neutropenic critically ill patients: results of the EPCAN observational study in EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
  • 2002-11-01. Prevention of severe Candida infections in nonneutropenic, high-risk, critically ill patients: a randomized, double-blind, placebo-controlled trial in patients treated by selective digestive decontamination in INTENSIVE CARE MEDICINE
  • Identifiers

    URI

    http://scigraph.springernature.com/pub.10.2165/10898550-000000000-00000

    DOI

    http://dx.doi.org/10.2165/10898550-000000000-00000

    DIMENSIONS

    https://app.dimensions.ai/details/publication/pub.1028372769

    PUBMED

    https://www.ncbi.nlm.nih.gov/pubmed/20426495


    Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
    Incoming Citations Browse incoming citations for this publication using opencitations.net

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Medical and Health Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Clinical Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Animals", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Antifungal Agents", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Candida", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Candidiasis", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Drug Administration Schedule", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Humans", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Intensive Care Units", 
            "type": "DefinedTerm"
          }
        ], 
        "author": [
          {
            "affiliation": {
              "alternateName": "Centre for Clinical Research, University of Queensland, Brisbane, Queensland, Australia", 
              "id": "http://www.grid.ac/institutes/grid.1003.2", 
              "name": [
                "Infection Management Services, Princess Alexandra Hospital, Ipswich Road, Woolloongabba, 4102, Brisbane, Queensland, Australia", 
                "Centre for Clinical Research, University of Queensland, Brisbane, Queensland, Australia"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Playford", 
            "givenName": "E. Geoffrey", 
            "id": "sg:person.01371076461.53", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01371076461.53"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Intensive Care, Royal Brisbane and Women\u2019s Hospital, Brisbane, Queensland, Australia", 
              "id": "http://www.grid.ac/institutes/grid.416100.2", 
              "name": [
                "Burns Trauma Critical Care Research Centre, University of Queensland, Brisbane, Queensland, Australia", 
                "Department of Intensive Care, Royal Brisbane and Women\u2019s Hospital, Brisbane, Queensland, Australia"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Lipman", 
            "givenName": "Jeff", 
            "id": "sg:person.01154534153.49", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01154534153.49"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia", 
              "id": "http://www.grid.ac/institutes/grid.1013.3", 
              "name": [
                "Centre for Infectious Diseases and Microbiology, Westmead Hospital, Sydney, New South Wales, Australia", 
                "Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Sorrell", 
            "givenName": "Tania C.", 
            "id": "sg:person.01003151017.13", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01003151017.13"
            ], 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "sg:pub.10.1007/s00134-005-2807-x", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1030076590", 
              "https://doi.org/10.1007/s00134-005-2807-x"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00134-005-2794-y", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1042652182", 
              "https://doi.org/10.1007/s00134-005-2794-y"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s10096-008-0618-z", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1017978603", 
              "https://doi.org/10.1007/s10096-008-0618-z"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s10096-008-0666-4", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1035274257", 
              "https://doi.org/10.1007/s10096-008-0666-4"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00268-004-7302-y", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1040069550", 
              "https://doi.org/10.1007/s00268-004-7302-y"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/bf01726360", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1015769866", 
              "https://doi.org/10.1007/bf01726360"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.2165/11318140-000000000-00000", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1039277611", 
              "https://doi.org/10.2165/11318140-000000000-00000"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/bf01713042", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1008950160", 
              "https://doi.org/10.1007/bf01713042"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1186/1471-2334-6-21", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1030116738", 
              "https://doi.org/10.1186/1471-2334-6-21"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00134-009-1619-9", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1003995862", 
              "https://doi.org/10.1007/s00134-009-1619-9"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/bf01695658", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1052599514", 
              "https://doi.org/10.1007/bf01695658"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s002280000216", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1004744481", 
              "https://doi.org/10.1007/s002280000216"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s001340050286", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1021049647", 
              "https://doi.org/10.1007/s001340050286"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00134-002-1540-y", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1046624930", 
              "https://doi.org/10.1007/s00134-002-1540-y"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s10096-007-0270-z", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1037150606", 
              "https://doi.org/10.1007/s10096-007-0270-z"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00134-009-1432-5", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1031793193", 
              "https://doi.org/10.1007/s00134-009-1432-5"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s10096-002-0854-6", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1075236554", 
              "https://doi.org/10.1007/s10096-002-0854-6"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00134-009-1431-6", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1015399303", 
              "https://doi.org/10.1007/s00134-009-1431-6"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00134-008-1339-6", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1053260834", 
              "https://doi.org/10.1007/s00134-008-1339-6"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1186/1476-0711-8-23", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1009325542", 
              "https://doi.org/10.1186/1476-0711-8-23"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1186/cc3883", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1039216895", 
              "https://doi.org/10.1186/cc3883"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00134-005-2806-y", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1028119312", 
              "https://doi.org/10.1007/s00134-005-2806-y"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00134-003-2002-x", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1035019108", 
              "https://doi.org/10.1007/s00134-003-2002-x"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/bf01690507", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1050670353", 
              "https://doi.org/10.1007/bf01690507"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1186/cc7964", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1020678115", 
              "https://doi.org/10.1186/cc7964"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00134-007-0865-y", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1004256795", 
              "https://doi.org/10.1007/s00134-007-0865-y"
            ], 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "2010-05", 
        "datePublishedReg": "2010-05-01", 
        "description": "Invasive candidiasis (IC) is an important infection in the intensive care unit (ICU) setting given its association with poor clinical outcomes. The epidemiology of IC is complex and, although incompletely elucidated, is characterized by considerable regional and temporal variability. Overall, there appears to be an increase in the incidence of IC and a change in distribution of the causative Candida spp. Of particular concern is an increase in the proportion of episodes caused by Candida glabrata, which is associated with reduced susceptibility to azole antifungal agents.The management of IC has been aided by the availability of several new antifungal agents. In particular, given their broad spectrum of activity and low toxicity, the use of echinocandins as first-line therapy is increasing, especially in settings where fluconazole-resistant Candida spp. are prevalent. Fluconazole remains a reliable agent where an azole-susceptible pathogen is confirmed or in settings where resistance is uncommon. Lipid formulations of amphotericin B are now generally reserved as second-line or salvage therapy. Voriconazole and posaconazole currently enjoy limited use for IC in the ICU setting.Although the poor outcomes associated with IC are, in part, related to the severity of underlying host factors, it is clear that optimization of treatment-related factors is also important. In particular, the speed of initiation of antifungal therapy and the achievement of pharmacodynamic parameters both influence outcomes. The most difficult challenge is early initiation of an effective antifungal drug, given the slow turnaround time and lack of sensitivity of conventional culture-based diagnostic techniques. New approaches, such as non-culture-based assays and/or clinical risk-predictive models are required to better target prophylactic, pre-emptive and empirical antifungal strategies.", 
        "genre": "article", 
        "id": "sg:pub.10.2165/10898550-000000000-00000", 
        "isAccessibleForFree": false, 
        "isFundedItemOf": [
          {
            "id": "sg:grant.6728525", 
            "type": "MonetaryGrant"
          }, 
          {
            "id": "sg:grant.6718257", 
            "type": "MonetaryGrant"
          }
        ], 
        "isPartOf": [
          {
            "id": "sg:journal.1084788", 
            "issn": [
              "0012-6667", 
              "1179-1950"
            ], 
            "name": "Drugs", 
            "publisher": "Springer Nature", 
            "type": "Periodical"
          }, 
          {
            "issueNumber": "7", 
            "type": "PublicationIssue"
          }, 
          {
            "type": "PublicationVolume", 
            "volumeNumber": "70"
          }
        ], 
        "keywords": [
          "invasive candidiasis", 
          "incidence of IC", 
          "management of IC", 
          "intensive care unit setting", 
          "Candida spp", 
          "use of echinocandins", 
          "proportion of episodes", 
          "first-line therapy", 
          "epidemiology of IC", 
          "treatment-related factors", 
          "fluconazole-resistant Candida spp", 
          "intensive care unit", 
          "poor clinical outcome", 
          "risk predictive model", 
          "antifungal agents", 
          "empirical antifungal strategies", 
          "effective antifungal drugs", 
          "salvage therapy", 
          "clinical outcomes", 
          "poor outcome", 
          "care unit", 
          "ICU setting", 
          "new antifungal agents", 
          "antifungal therapy", 
          "unit setting", 
          "speed of initiation", 
          "pharmacodynamic parameters", 
          "early initiation", 
          "important infections", 
          "amphotericin B", 
          "influence outcomes", 
          "host factors", 
          "therapy", 
          "reduced susceptibility", 
          "lipid formulations", 
          "antifungal drugs", 
          "slow turnaround time", 
          "candidiasis", 
          "outcomes", 
          "Candida glabrata", 
          "diagnostic techniques", 
          "antifungal strategies", 
          "lack of sensitivity", 
          "reliable agent", 
          "setting", 
          "agents", 
          "broad spectrum", 
          "turnaround time", 
          "low toxicity", 
          "voriconazole", 
          "initiation", 
          "infection", 
          "posaconazole", 
          "epidemiology", 
          "incidence", 
          "echinocandins", 
          "fluconazole", 
          "severity", 
          "particular concern", 
          "drugs", 
          "management", 
          "episodes", 
          "factors", 
          "association", 
          "toxicity", 
          "glabrata", 
          "increase", 
          "assays", 
          "pathogens", 
          "spp", 
          "proportion", 
          "susceptibility", 
          "use", 
          "difficult challenge", 
          "activity", 
          "sensitivity", 
          "lack", 
          "resistance", 
          "changes", 
          "concern", 
          "strategies", 
          "units", 
          "time", 
          "variability", 
          "challenges", 
          "availability", 
          "part", 
          "new approach", 
          "technique", 
          "model", 
          "approach", 
          "formulation", 
          "parameters", 
          "distribution", 
          "achievement", 
          "spectra", 
          "speed", 
          "optimization", 
          "temporal variability"
        ], 
        "name": "Management of Invasive Candidiasis in the Intensive Care Unit", 
        "pagination": "823-839", 
        "productId": [
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "pub.1028372769"
            ]
          }, 
          {
            "name": "doi", 
            "type": "PropertyValue", 
            "value": [
              "10.2165/10898550-000000000-00000"
            ]
          }, 
          {
            "name": "pubmed_id", 
            "type": "PropertyValue", 
            "value": [
              "20426495"
            ]
          }
        ], 
        "sameAs": [
          "https://doi.org/10.2165/10898550-000000000-00000", 
          "https://app.dimensions.ai/details/publication/pub.1028372769"
        ], 
        "sdDataset": "articles", 
        "sdDatePublished": "2022-12-01T06:28", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20221201/entities/gbq_results/article/article_507.jsonl", 
        "type": "ScholarlyArticle", 
        "url": "https://doi.org/10.2165/10898550-000000000-00000"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.2165/10898550-000000000-00000'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.2165/10898550-000000000-00000'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.2165/10898550-000000000-00000'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.2165/10898550-000000000-00000'


     

    This table displays all metadata directly associated to this object as RDF triples.

    319 TRIPLES      21 PREDICATES      158 URIs      124 LITERALS      14 BLANK NODES

    Subject Predicate Object
    1 sg:pub.10.2165/10898550-000000000-00000 schema:about N278be5fe83d24d3bba221d2d94b09419
    2 N623b61aa89db4f55bb8bb788110fea4c
    3 Na52261fd91cb48e9bc7b8a79c0d17fcc
    4 Nb36be3af499649a4abcd30ea78c1d253
    5 Nbcc0774cd92f48c1b58648f0af2a6cee
    6 Nd9f3440ec8e2471f8659b1c6012e1f8c
    7 Nebbdee03d14344119f5a5e976987b7f3
    8 anzsrc-for:11
    9 anzsrc-for:1103
    10 schema:author N3aedb58b3ee644ddb746c48f8d7c3b07
    11 schema:citation sg:pub.10.1007/bf01690507
    12 sg:pub.10.1007/bf01695658
    13 sg:pub.10.1007/bf01713042
    14 sg:pub.10.1007/bf01726360
    15 sg:pub.10.1007/s00134-002-1540-y
    16 sg:pub.10.1007/s00134-003-2002-x
    17 sg:pub.10.1007/s00134-005-2794-y
    18 sg:pub.10.1007/s00134-005-2806-y
    19 sg:pub.10.1007/s00134-005-2807-x
    20 sg:pub.10.1007/s00134-007-0865-y
    21 sg:pub.10.1007/s00134-008-1339-6
    22 sg:pub.10.1007/s00134-009-1431-6
    23 sg:pub.10.1007/s00134-009-1432-5
    24 sg:pub.10.1007/s00134-009-1619-9
    25 sg:pub.10.1007/s001340050286
    26 sg:pub.10.1007/s002280000216
    27 sg:pub.10.1007/s00268-004-7302-y
    28 sg:pub.10.1007/s10096-002-0854-6
    29 sg:pub.10.1007/s10096-007-0270-z
    30 sg:pub.10.1007/s10096-008-0618-z
    31 sg:pub.10.1007/s10096-008-0666-4
    32 sg:pub.10.1186/1471-2334-6-21
    33 sg:pub.10.1186/1476-0711-8-23
    34 sg:pub.10.1186/cc3883
    35 sg:pub.10.1186/cc7964
    36 sg:pub.10.2165/11318140-000000000-00000
    37 schema:datePublished 2010-05
    38 schema:datePublishedReg 2010-05-01
    39 schema:description Invasive candidiasis (IC) is an important infection in the intensive care unit (ICU) setting given its association with poor clinical outcomes. The epidemiology of IC is complex and, although incompletely elucidated, is characterized by considerable regional and temporal variability. Overall, there appears to be an increase in the incidence of IC and a change in distribution of the causative Candida spp. Of particular concern is an increase in the proportion of episodes caused by Candida glabrata, which is associated with reduced susceptibility to azole antifungal agents.The management of IC has been aided by the availability of several new antifungal agents. In particular, given their broad spectrum of activity and low toxicity, the use of echinocandins as first-line therapy is increasing, especially in settings where fluconazole-resistant Candida spp. are prevalent. Fluconazole remains a reliable agent where an azole-susceptible pathogen is confirmed or in settings where resistance is uncommon. Lipid formulations of amphotericin B are now generally reserved as second-line or salvage therapy. Voriconazole and posaconazole currently enjoy limited use for IC in the ICU setting.Although the poor outcomes associated with IC are, in part, related to the severity of underlying host factors, it is clear that optimization of treatment-related factors is also important. In particular, the speed of initiation of antifungal therapy and the achievement of pharmacodynamic parameters both influence outcomes. The most difficult challenge is early initiation of an effective antifungal drug, given the slow turnaround time and lack of sensitivity of conventional culture-based diagnostic techniques. New approaches, such as non-culture-based assays and/or clinical risk-predictive models are required to better target prophylactic, pre-emptive and empirical antifungal strategies.
    40 schema:genre article
    41 schema:isAccessibleForFree false
    42 schema:isPartOf N2853fbe61f014212b9ce95698a288d54
    43 N3d8bf2db184240f29dce0975fd91ff8c
    44 sg:journal.1084788
    45 schema:keywords Candida glabrata
    46 Candida spp
    47 ICU setting
    48 achievement
    49 activity
    50 agents
    51 amphotericin B
    52 antifungal agents
    53 antifungal drugs
    54 antifungal strategies
    55 antifungal therapy
    56 approach
    57 assays
    58 association
    59 availability
    60 broad spectrum
    61 candidiasis
    62 care unit
    63 challenges
    64 changes
    65 clinical outcomes
    66 concern
    67 diagnostic techniques
    68 difficult challenge
    69 distribution
    70 drugs
    71 early initiation
    72 echinocandins
    73 effective antifungal drugs
    74 empirical antifungal strategies
    75 epidemiology
    76 epidemiology of IC
    77 episodes
    78 factors
    79 first-line therapy
    80 fluconazole
    81 fluconazole-resistant Candida spp
    82 formulation
    83 glabrata
    84 host factors
    85 important infections
    86 incidence
    87 incidence of IC
    88 increase
    89 infection
    90 influence outcomes
    91 initiation
    92 intensive care unit
    93 intensive care unit setting
    94 invasive candidiasis
    95 lack
    96 lack of sensitivity
    97 lipid formulations
    98 low toxicity
    99 management
    100 management of IC
    101 model
    102 new antifungal agents
    103 new approach
    104 optimization
    105 outcomes
    106 parameters
    107 part
    108 particular concern
    109 pathogens
    110 pharmacodynamic parameters
    111 poor clinical outcome
    112 poor outcome
    113 posaconazole
    114 proportion
    115 proportion of episodes
    116 reduced susceptibility
    117 reliable agent
    118 resistance
    119 risk predictive model
    120 salvage therapy
    121 sensitivity
    122 setting
    123 severity
    124 slow turnaround time
    125 spectra
    126 speed
    127 speed of initiation
    128 spp
    129 strategies
    130 susceptibility
    131 technique
    132 temporal variability
    133 therapy
    134 time
    135 toxicity
    136 treatment-related factors
    137 turnaround time
    138 unit setting
    139 units
    140 use
    141 use of echinocandins
    142 variability
    143 voriconazole
    144 schema:name Management of Invasive Candidiasis in the Intensive Care Unit
    145 schema:pagination 823-839
    146 schema:productId N04202aa1c77b48eb91335fe0c1466080
    147 N9afa88c001904cb183ceab1ec054917c
    148 N9d7cfee7464e4624b296942ca5394f63
    149 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028372769
    150 https://doi.org/10.2165/10898550-000000000-00000
    151 schema:sdDatePublished 2022-12-01T06:28
    152 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    153 schema:sdPublisher Nf4dd6b5502e540b5bcb759b7b24b09d4
    154 schema:url https://doi.org/10.2165/10898550-000000000-00000
    155 sgo:license sg:explorer/license/
    156 sgo:sdDataset articles
    157 rdf:type schema:ScholarlyArticle
    158 N04202aa1c77b48eb91335fe0c1466080 schema:name pubmed_id
    159 schema:value 20426495
    160 rdf:type schema:PropertyValue
    161 N278be5fe83d24d3bba221d2d94b09419 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    162 schema:name Drug Administration Schedule
    163 rdf:type schema:DefinedTerm
    164 N2853fbe61f014212b9ce95698a288d54 schema:issueNumber 7
    165 rdf:type schema:PublicationIssue
    166 N394a142a97304205a7af90d487f12607 rdf:first sg:person.01154534153.49
    167 rdf:rest Na36ea161f7f7481d95b6ab15625d8046
    168 N3aedb58b3ee644ddb746c48f8d7c3b07 rdf:first sg:person.01371076461.53
    169 rdf:rest N394a142a97304205a7af90d487f12607
    170 N3d8bf2db184240f29dce0975fd91ff8c schema:volumeNumber 70
    171 rdf:type schema:PublicationVolume
    172 N623b61aa89db4f55bb8bb788110fea4c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    173 schema:name Humans
    174 rdf:type schema:DefinedTerm
    175 N9afa88c001904cb183ceab1ec054917c schema:name doi
    176 schema:value 10.2165/10898550-000000000-00000
    177 rdf:type schema:PropertyValue
    178 N9d7cfee7464e4624b296942ca5394f63 schema:name dimensions_id
    179 schema:value pub.1028372769
    180 rdf:type schema:PropertyValue
    181 Na36ea161f7f7481d95b6ab15625d8046 rdf:first sg:person.01003151017.13
    182 rdf:rest rdf:nil
    183 Na52261fd91cb48e9bc7b8a79c0d17fcc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    184 schema:name Candidiasis
    185 rdf:type schema:DefinedTerm
    186 Nb36be3af499649a4abcd30ea78c1d253 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    187 schema:name Intensive Care Units
    188 rdf:type schema:DefinedTerm
    189 Nbcc0774cd92f48c1b58648f0af2a6cee schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    190 schema:name Animals
    191 rdf:type schema:DefinedTerm
    192 Nd9f3440ec8e2471f8659b1c6012e1f8c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    193 schema:name Candida
    194 rdf:type schema:DefinedTerm
    195 Nebbdee03d14344119f5a5e976987b7f3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    196 schema:name Antifungal Agents
    197 rdf:type schema:DefinedTerm
    198 Nf4dd6b5502e540b5bcb759b7b24b09d4 schema:name Springer Nature - SN SciGraph project
    199 rdf:type schema:Organization
    200 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
    201 schema:name Medical and Health Sciences
    202 rdf:type schema:DefinedTerm
    203 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
    204 schema:name Clinical Sciences
    205 rdf:type schema:DefinedTerm
    206 sg:grant.6718257 http://pending.schema.org/fundedItem sg:pub.10.2165/10898550-000000000-00000
    207 rdf:type schema:MonetaryGrant
    208 sg:grant.6728525 http://pending.schema.org/fundedItem sg:pub.10.2165/10898550-000000000-00000
    209 rdf:type schema:MonetaryGrant
    210 sg:journal.1084788 schema:issn 0012-6667
    211 1179-1950
    212 schema:name Drugs
    213 schema:publisher Springer Nature
    214 rdf:type schema:Periodical
    215 sg:person.01003151017.13 schema:affiliation grid-institutes:grid.1013.3
    216 schema:familyName Sorrell
    217 schema:givenName Tania C.
    218 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01003151017.13
    219 rdf:type schema:Person
    220 sg:person.01154534153.49 schema:affiliation grid-institutes:grid.416100.2
    221 schema:familyName Lipman
    222 schema:givenName Jeff
    223 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01154534153.49
    224 rdf:type schema:Person
    225 sg:person.01371076461.53 schema:affiliation grid-institutes:grid.1003.2
    226 schema:familyName Playford
    227 schema:givenName E. Geoffrey
    228 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01371076461.53
    229 rdf:type schema:Person
    230 sg:pub.10.1007/bf01690507 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050670353
    231 https://doi.org/10.1007/bf01690507
    232 rdf:type schema:CreativeWork
    233 sg:pub.10.1007/bf01695658 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052599514
    234 https://doi.org/10.1007/bf01695658
    235 rdf:type schema:CreativeWork
    236 sg:pub.10.1007/bf01713042 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008950160
    237 https://doi.org/10.1007/bf01713042
    238 rdf:type schema:CreativeWork
    239 sg:pub.10.1007/bf01726360 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015769866
    240 https://doi.org/10.1007/bf01726360
    241 rdf:type schema:CreativeWork
    242 sg:pub.10.1007/s00134-002-1540-y schema:sameAs https://app.dimensions.ai/details/publication/pub.1046624930
    243 https://doi.org/10.1007/s00134-002-1540-y
    244 rdf:type schema:CreativeWork
    245 sg:pub.10.1007/s00134-003-2002-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1035019108
    246 https://doi.org/10.1007/s00134-003-2002-x
    247 rdf:type schema:CreativeWork
    248 sg:pub.10.1007/s00134-005-2794-y schema:sameAs https://app.dimensions.ai/details/publication/pub.1042652182
    249 https://doi.org/10.1007/s00134-005-2794-y
    250 rdf:type schema:CreativeWork
    251 sg:pub.10.1007/s00134-005-2806-y schema:sameAs https://app.dimensions.ai/details/publication/pub.1028119312
    252 https://doi.org/10.1007/s00134-005-2806-y
    253 rdf:type schema:CreativeWork
    254 sg:pub.10.1007/s00134-005-2807-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1030076590
    255 https://doi.org/10.1007/s00134-005-2807-x
    256 rdf:type schema:CreativeWork
    257 sg:pub.10.1007/s00134-007-0865-y schema:sameAs https://app.dimensions.ai/details/publication/pub.1004256795
    258 https://doi.org/10.1007/s00134-007-0865-y
    259 rdf:type schema:CreativeWork
    260 sg:pub.10.1007/s00134-008-1339-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1053260834
    261 https://doi.org/10.1007/s00134-008-1339-6
    262 rdf:type schema:CreativeWork
    263 sg:pub.10.1007/s00134-009-1431-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015399303
    264 https://doi.org/10.1007/s00134-009-1431-6
    265 rdf:type schema:CreativeWork
    266 sg:pub.10.1007/s00134-009-1432-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031793193
    267 https://doi.org/10.1007/s00134-009-1432-5
    268 rdf:type schema:CreativeWork
    269 sg:pub.10.1007/s00134-009-1619-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003995862
    270 https://doi.org/10.1007/s00134-009-1619-9
    271 rdf:type schema:CreativeWork
    272 sg:pub.10.1007/s001340050286 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021049647
    273 https://doi.org/10.1007/s001340050286
    274 rdf:type schema:CreativeWork
    275 sg:pub.10.1007/s002280000216 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004744481
    276 https://doi.org/10.1007/s002280000216
    277 rdf:type schema:CreativeWork
    278 sg:pub.10.1007/s00268-004-7302-y schema:sameAs https://app.dimensions.ai/details/publication/pub.1040069550
    279 https://doi.org/10.1007/s00268-004-7302-y
    280 rdf:type schema:CreativeWork
    281 sg:pub.10.1007/s10096-002-0854-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1075236554
    282 https://doi.org/10.1007/s10096-002-0854-6
    283 rdf:type schema:CreativeWork
    284 sg:pub.10.1007/s10096-007-0270-z schema:sameAs https://app.dimensions.ai/details/publication/pub.1037150606
    285 https://doi.org/10.1007/s10096-007-0270-z
    286 rdf:type schema:CreativeWork
    287 sg:pub.10.1007/s10096-008-0618-z schema:sameAs https://app.dimensions.ai/details/publication/pub.1017978603
    288 https://doi.org/10.1007/s10096-008-0618-z
    289 rdf:type schema:CreativeWork
    290 sg:pub.10.1007/s10096-008-0666-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035274257
    291 https://doi.org/10.1007/s10096-008-0666-4
    292 rdf:type schema:CreativeWork
    293 sg:pub.10.1186/1471-2334-6-21 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030116738
    294 https://doi.org/10.1186/1471-2334-6-21
    295 rdf:type schema:CreativeWork
    296 sg:pub.10.1186/1476-0711-8-23 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009325542
    297 https://doi.org/10.1186/1476-0711-8-23
    298 rdf:type schema:CreativeWork
    299 sg:pub.10.1186/cc3883 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039216895
    300 https://doi.org/10.1186/cc3883
    301 rdf:type schema:CreativeWork
    302 sg:pub.10.1186/cc7964 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020678115
    303 https://doi.org/10.1186/cc7964
    304 rdf:type schema:CreativeWork
    305 sg:pub.10.2165/11318140-000000000-00000 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039277611
    306 https://doi.org/10.2165/11318140-000000000-00000
    307 rdf:type schema:CreativeWork
    308 grid-institutes:grid.1003.2 schema:alternateName Centre for Clinical Research, University of Queensland, Brisbane, Queensland, Australia
    309 schema:name Centre for Clinical Research, University of Queensland, Brisbane, Queensland, Australia
    310 Infection Management Services, Princess Alexandra Hospital, Ipswich Road, Woolloongabba, 4102, Brisbane, Queensland, Australia
    311 rdf:type schema:Organization
    312 grid-institutes:grid.1013.3 schema:alternateName Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia
    313 schema:name Centre for Infectious Diseases and Microbiology, Westmead Hospital, Sydney, New South Wales, Australia
    314 Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia
    315 rdf:type schema:Organization
    316 grid-institutes:grid.416100.2 schema:alternateName Department of Intensive Care, Royal Brisbane and Women’s Hospital, Brisbane, Queensland, Australia
    317 schema:name Burns Trauma Critical Care Research Centre, University of Queensland, Brisbane, Queensland, Australia
    318 Department of Intensive Care, Royal Brisbane and Women’s Hospital, Brisbane, Queensland, Australia
    319 rdf:type schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...